These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 35758097)

  • 61. Liquid biopsy for precision diagnostics and therapeutics.
    Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
    Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
    Addanki S; Meas S; Sarli VN; Singh B; Lucci A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.
    Aquino IMC; Pascut D
    Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
    Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
    Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The prospect and challenge of liquid biopsy in the diagnosis and treatment of chest malignancy].
    Ma LF; Zeng BJ; Wang XZ; Zhang X; Wang JY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):968-975. PubMed ID: 37482733
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer.
    Mollica V; Di Nunno V; Santoni M; Cimadamore A; Scarpelli M; Lopez-Beltran A; Cheng L; Mariani C; Battelli N; Montironi R; Massari F
    Expert Rev Mol Diagn; 2020 Feb; 20(2):207-217. PubMed ID: 31640441
    [No Abstract]   [Full Text] [Related]  

  • 70. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
    Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential clinical utility of liquid biopsies in ovarian cancer.
    Zhu JW; Charkhchi P; Akbari MR
    Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
    Marrugo-Ramírez J; Mir M; Samitier J
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Current Status and Prospects of Liquid Biopsy for Hepatocellular Carcinoma].
    Kang J; Kim SS
    Korean J Gastroenterol; 2023 Jul; 82(1):1-9. PubMed ID: 37489076
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications.
    Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S
    Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.
    Lee YT; Sun N; Kim M; Wang JJ; Tran BV; Zhang RY; Qi D; Zhang C; Chen PJ; Sadeghi S; Finn RS; Saab S; Han SB; Busuttil RW; Pei R; Zhu Y; Tseng HR; You S; Yang JD; Agopian VG
    Liver Transpl; 2022 Feb; 28(2):200-214. PubMed ID: 34664394
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
    Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
    J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Liquid biopsy in prostate cancer: A novel dual biomarker analysis approach integrating circulating tumor cells and circulating tumor DNA data.
    Li Q; Tang L; Zhao Y; Li Z; Ma W; Ma L
    Cell Mol Biol (Noisy-le-grand); 2024 Sep; 70(8):158-163. PubMed ID: 39262247
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.
    Tao XY; Li QQ; Zeng Y
    Mol Cancer; 2024 Jul; 23(1):145. PubMed ID: 39014366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.